225 results
8-K
TXMD
TherapeuticsMD Inc
10 Jul 23
Changes in Registrant's Certifying Accountant
5:20pm
to the satisfaction of GT, would have caused GT to make reference to the subject matter of the disagreement in connection with its report.
During
8-K
TXMD
TherapeuticsMD Inc
5 May 23
Entry into a Material Definitive Agreement
5:26pm
and each draw down is subject to the satisfaction or waiver of certain conditions, including that the Company’s stockholders vote to approve the Private
8-K
EX-10.2
gixiwxs79jp
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-99.1
5d0ts sezf9tdxp6t4d
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-10.2
qxbgljjyhk1jvuw35oa
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
x5ibvtjqs
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
dmtlnv fl8m
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.2
fp1yypmlooqd2u px
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.1
720uh6jtzeymii7
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am